Výsledky vyhledávání - "Schoemaker, RG"

Akademický článek

SK-Channel Activation Alters Peripheral Metabolic Pathways in Mice, but Not Lipopolysaccharide-Induced Fever or Inflammation

Autor: Bredehöft J, Dolga AM, Honrath B, Wache S, Mazurek S, Culmsee C, Schoemaker RG, Gerstberger R, Roth J, Rummel C

Publikováno v: Journal of Inflammation Research, Vol Volume 15, Pp 509-531 (2022)

Janne Bredehöft,1 Amalia M Dolga,2 Birgit Honrath,2,3 Sybille Wache,1 Sybille Mazurek,1 Carsten Culmsee,3,4 Regien G Schoemaker,5 Rüdiger Gerstberger,1 Joachim Roth,1,4 Christoph Rummel1,4 1Institute of Veterinary Physiology and Biochemistry, Justu

Externí odkaz: https://doaj.org/article/03e7631be63b425b8a671336efa92a21

Zobrazit plný text záznamu

Coronary stent healing, endothelialisation and the role of co-medication

Autor: van Beusekom, H.M.M., Schoemaker, RG (Regien), Roks, Anton, Zijlstra, Freek, Giessen, Wim

Publikováno v: Netherlands Heart Journal, 15, 395-396. Bohn Stafleu van Loghum

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::2ce6bfedc0d5ccd6a63730e52754eb6a
https://pure.eur.nl/en/publications/10083a7c-0f5c-44c2-9b60-da9ea378a5f9

Zobrazit plný text záznamu

Genomic and nongenomic effects of aldosterone in the rat heart: why is spironolactone cardioprotective?

Autor: Chai, W (Wenxia), Van den Berg - Garrelds, Ingrid, Arulmani, US (Udayasankar), Schoemaker, RG (Regien), Lamers, Jos, Danser, AHJ

Publikováno v: British Journal of Pharmacology, 145(5), 664-671. Wiley-Blackwell

1 Mineralocorticoid receptor (MR) antagonism with spironolactone reduces mortality in heart failure on top of ACE inhibition. To investigate the underlying mechanism, we compared the actions of both aldosterone and spironolactone to those of angioten

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::50da7e70bf6059189538b0b47ba3a9a2
https://research.rug.nl/en/publications/d505bdd5-4d34-46c8-acfa-685b388f5306

Zobrazit plný text záznamu

Timing of erythropoietin treatment for cardioprotection in ischemia/reperfusion

Autor: Lipsic, E, van der Meer, P, Henning, RH, Suurmeijer, AJH, Boddeus, KM, van Veldhuisen, DJ, van Gilst, WH, Schoemaker, RG

Publikováno v: Journal of Cardiovascular Pharmacology, 44(4), 473-479

Erythropoietin (EPO) is a hormone known to stimulate hematopoiesis. However, recent research suggests additional properties of EPO, such as protection against ischemia/reperfusion (I/R) injury in various tissues. We studied the effect of timing of EP

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::441c81b9195da4478b36b045b8045748
https://research.rug.nl/en/publications/14e1f3e0-cfc6-4e26-bfb6-5a91834b6ccd

Zobrazit plný text záznamu